Join the fastest growing community of drug discovery innovators
Cut through the noise and discover breakthroughs. Expertly researched & to-the-point content makes keeping up with the industry easy.
By subscribing to our newsletter, you agree to our Terms and Conditions and Privacy Policy. Unsubscribe anytime.
Be sure to whitelist the @drughunter.com domain in your e-mail inbox to make sure your free content doesn't get sent to spam!
From Our Members
“I continue to be surprised on how the issues your publication touches on routinely seems to impact our work lives in the sense of prompting conversations, prompting literature or patent searches based on the work of others facing similar challenges. The value of this very direct effect can’t be overstated gi..."
Peter Meinke
Sanders Director, Tri-I TDI + 28 yrs at Merck
Popular Content
- 1.2023 Novel Small Molecule FDA Drug Approvals
- 2.Top 12 Most Popular Drug Hunter Case Studies of 2023
- 3.Top Ten Most Popular Drug Hunter Resources of 2023
- 4.Top 10 Most Popular Drug Hunter Review Articles of 2023
- 5.Practical PK Calculators
- 6.AACR Orlando 2023: New Drug Candidates
- 7.PK Cheat Sheet
- 8.Phase I Drug Metabolism
- 9.Why pKas Matter in Medicinal Chemistry and a Drug Discovery Amine pKa Table
- 10.Phase II Drug Metabolism
- 11.First Disclosures from ACS Chicago 2022
- 12.Topliss Tree and Topliss Scheme Posters
VIEW MORE CONTENT